Helical’s $10M Seed Wants a Virtual AI Lab for Pharma — Finally, a Wet-Lab Hall Pass
Helical just raised $10M to turn bio foundation models into a virtual pharma lab. The pitch is grand, but this one might actually earn the pipettes.
Biotech
IO Biotech Discovers the Strategic Alternative Is “Hiring a Banker”
IO Biotech (Nasdaq: IOBT) cost containment, workforce reduction, and the soft language of biotech distress.
This New Tokyo Microscope Ends 400 Years of Cellular Guesswork
Tokyo’s new “Great Unified Microscope” sees micro and nano worlds at once—finally showing cells can’t hide their secrets anymore.
Nomic Bio’s nELISA Tech Makes Proteomics Scalable, and Surprisingly Cool
Nomic Bio publishes its nELISA proteomics platform in Nature Methods, unveiling a 1.4 million–protein dataset and a browser-based Nomic Portal. Here’s why that actually matters — and how it could reshape drug discovery.